Evaluation of different concentration of ropivacaine used in ultrasound-guided posterior quadratus lumborum block for perioperative analgesia after laparoscopic herniorrhaphy surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000031690

Enrollment

Unknown

Registered

2020-04-07

Start date

2020-04-20

Completion date

Unknown

Last updated

2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inguinal hernia

Interventions

H group:0.375% ropivacaine

L group:0.2%ropivacaine

Eligibility

Sex/Gender

All

Age

25 Years to 75 Years

Inclusion criteria

Inclusion criteria: ASA I-III, 25-75 years old, patients undergoing selective laparoscopic hernia repair surgery in the Second Hospital of ShanDong University.

Exclusion criteria

Exclusion criteria: Severe cardiovascular and cerebrovascular diseases, liver and kidney dysfunction, BMI > 35kg / m2, peripheral neuropathy, local anesthetic allergy, infection at puncture site, coagulation dysfunction, mental illness, communication disorder can not cooperate

Design outcomes

Primary

Measure	Time frame
dosage of opioid drug;Postoperative NRSS score;	—

Countries

China

Contacts

Public ContactXin Zhao

The Second Hospital of Shandong University

1094437609@qq.com+86 17660085551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026